Literature DB >> 12904874

[Statin-induced Parkinson's-syndrome. Reader's letter on the article by J. Finsterer in "Der Nervenarzt" (2003) 74:115-122].

Th Müller1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12904874     DOI： 10.1007/s00115-003-1528-z

Source DB:  PubMed          Journal:  Nervenarzt        ISSN： 0028-2804            Impact factor:   1.214


× No keyword cloud information.
  13 in total

1.  The biochemical bases for reward. Implications for the placebo effect.

Authors:  Raúl De La Fuente-Fernández; A Jon Stoessl
Journal:  Eval Health Prof       Date:  2002-12       Impact factor: 2.651

2.  Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial.

Authors:  Mikael Simons; Frank Schwärzler; Dieter Lütjohann; Klaus von Bergmann; Konrad Beyreuther; Johannes Dichgans; Henning Wormstall; Tobias Hartmann; Jörg B Schulz
Journal:  Ann Neurol       Date:  2002-09       Impact factor: 10.422

3.  Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease.

Authors:  Thomas Müller; Thomas Büttner; Ali Farshad Gholipour; Wilfried Kuhn
Journal:  Neurosci Lett       Date:  2003-05-08       Impact factor: 3.046

4.  Metabolic changes in patients with mitochondrial myopathies and effects of coenzyme Q10 therapy.

Authors:  A Chan; H Reichmann; A Kögel; A Beck; R Gold
Journal:  J Neurol       Date:  1998-10       Impact factor: 4.849

5.  Assessment of coenzyme Q10 tolerability in Huntington's disease.

Authors:  A Feigin; K Kieburtz; P Como; C Hickey; K Claude; D Abwender; C Zimmerman; K Steinberg; I Shoulson
Journal:  Mov Disord       Date:  1996-05       Impact factor: 10.338

6.  Lovastatin decreases coenzyme Q levels in humans.

Authors:  K Folkers; P Langsjoen; R Willis; P Richardson; L J Xia; C Q Ye; H Tamagawa
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

7.  Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency.

Authors:  A Rötig; E L Appelkvist; V Geromel; D Chretien; N Kadhom; P Edery; M Lebideau; G Dallner; A Munnich; L Ernster; P Rustin
Journal:  Lancet       Date:  2000-07-29       Impact factor: 79.321

8.  Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline.

Authors:  Clifford W Shults; David Oakes; Karl Kieburtz; M Flint Beal; Richard Haas; Sandy Plumb; Jorge L Juncos; John Nutt; Ira Shoulson; Julie Carter; Katie Kompoliti; Joel S Perlmutter; Stephen Reich; Matthew Stern; Ray L Watts; Roger Kurlan; Eric Molho; Madaline Harrison; Mark Lew
Journal:  Arch Neurol       Date:  2002-10

9.  Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects.

Authors:  C W Shults; R H Haas; D Passov; M F Beal
Journal:  Ann Neurol       Date:  1997-08       Impact factor: 10.422

Review 10.  [Fibrate and statine myopathy].

Authors:  J Finsterer
Journal:  Nervenarzt       Date:  2003-02       Impact factor: 1.214
View more
  1 in total

1.  Use of statins and the risk of Parkinson's disease: a retrospective case-control study in the UK.

Authors:  Claudia Becker; Susan S Jick; Christoph R Meier
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.